Cargando…

ACE for all – a molecular perspective

Angiotensin-I converting enzyme (ACE, EC 3.4.15.1) is a zinc dependent dipeptidyl carboxypeptidase with an essential role in mammalian blood pressure regulation as part of the renin-angiotensin aldosterone system (RAAS). As such, it has long been targeted in the treatment of hypertension through the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrison, Charlotte, Acharya, K. Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165820/ https://www.ncbi.nlm.nih.gov/pubmed/25027949 http://dx.doi.org/10.1007/s12079-014-0236-8

Ejemplares similares

ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV
por: Lubbe, Lizelle, et al.
Publicado: (2020)

Molecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)
por: Yates, Christopher J., et al.
Publicado: (2014)

Crystal structures of sampatrilat and sampatrilat‐Asp in complex with human ACE – a molecular basis for domain selectivity
por: Cozier, Gyles E., et al.
Publicado: (2018)

Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
por: Masuyer, Geoffrey, et al.
Publicado: (2012)

Ace revisited: A new target for structure-based drug design
por: Acharya, K. Ravi, et al.
Publicado: (2003)

ACE-domain selectivity extends beyond direct interacting residues at the active site
por: Cozier, Gyles E., et al.
Publicado: (2020)

A new high-resolution crystal structure of the Drosophila melanogaster angiotensin converting enzyme homologue, AnCE
por: Harrison, Charlotte, et al.
Publicado: (2015)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Molecular Imaging of ACE2 Expression in Infectious Disease and Cancer
por: Li, Zhiyao, et al.
Publicado: (2023)

TAVR for All? The Surgical Perspective
por: Zhang, Xiling, et al.
Publicado: (2022)

Absence of cell surface expression of human ACE leads to perinatal death
por: Michaud, Annie, et al.
Publicado: (2014)

The Importance of Screening for Adverse Childhood Experiences (ACE) in all Medical Encounters
por: Gordon, Jeoffry B., et al.
Publicado: (2023)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

ACE and ACE2: insights from Drosophila and implications for COVID-19
por: Herrera, Paul, et al.
Publicado: (2021)

A historical perspective on ACE2 in the COVID-19 era
por: Bhalla, Vivek, et al.
Publicado: (2020)

Tying the knot: The cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines
por: Iyer, Shalini, et al.
Publicado: (2011)

Characterization of the first angiotensin-converting like enzyme in bacteria: Ancestor ACE is already active
por: Rivière, Guillaume, et al.
Publicado: (2007)

Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide
por: Akif, Mohd, et al.
Publicado: (2011)

Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors
por: Chamata, Yara, et al.
Publicado: (2020)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
por: Kunvariya, Aditi D., et al.
Publicado: (2023)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
por: Kaur, Upinder, et al.
Publicado: (2020)

A brain for all seasons: An in vivo MRI perspective on songbirds
por: Orije, Jasmien Ellen Maria Jozef, et al.
Publicado: (2022)

ACE2, Metformin, and COVID-19
por: Malhotra, Atul, et al.
Publicado: (2020)

Mosby's Ace the Boards Series
por: Farsad, Khashayar
Publicado: (1998)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection
por: Lata, Sneh, et al.
Publicado: (2022)

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients
por: Zamai, Loris
Publicado: (2020)

Current perspectives in T-ALL
por: Ferrando, Adolfo
Publicado: (2019)

Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007)

ACE2 and COVID-19 and the resulting ARDS
por: Zhang, Xiaoqing, et al.
Publicado: (2020)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
por: Sieńko, Jerzy, et al.
Publicado: (2020)

Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system
por: Guang, Cuie, et al.
Publicado: (2012)

Molecular imaging on ACE2‐dependent transocular infection of coronavirus
por: Li, Danni, et al.
Publicado: (2022)

Decipering the Molecular Mechanism of ACE2 Regulating A549 Cells
por: Xiao, Kun, et al.
Publicado: (2021)

Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study
por: Parit, Rahul, et al.
Publicado: (2021)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

RAAS, ACE2 and COVID-19; a mechanistic review
por: Elshafei, Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufpo98lel96hpu69daj0tnsv26